Dihydroouabain (DHO, 1183-35-3) has been identified as an endogenous ouabain-like effector of sodium-potassium ATPase in mouse1 and human2 adrenal cells. Micromolar to millimolar concentrations of DHO are known to inhibit Na/K pump activity3 and nanomola
* VAT and and shipping costs not included. Errors and price changes excepted